Clinical Pharmacology Studies in China: A Regulatory Perspective
Clinical Pharmacology Studies in China: A Regulatory Perspective Regulatory Insights into Clinical Pharmacology Studies in China Introduction Clinical pharmacology studies form the foundation of drug development, generating essential data on pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, and bioequivalence. In China, these studies have gained increasing regulatory importance as the National Medical Products Administration (NMPA) has modernized…
Read More “Clinical Pharmacology Studies in China: A Regulatory Perspective” »